Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3461311rdf:typepubmed:Citationlld:pubmed
pubmed-article:3461311lifeskim:mentionsumls-concept:C0030193lld:lifeskim
pubmed-article:3461311lifeskim:mentionsumls-concept:C0025148lld:lifeskim
pubmed-article:3461311lifeskim:mentionsumls-concept:C0001629lld:lifeskim
pubmed-article:3461311lifeskim:mentionsumls-concept:C1550278lld:lifeskim
pubmed-article:3461311lifeskim:mentionsumls-concept:C0521329lld:lifeskim
pubmed-article:3461311lifeskim:mentionsumls-concept:C0205322lld:lifeskim
pubmed-article:3461311lifeskim:mentionsumls-concept:C0851285lld:lifeskim
pubmed-article:3461311lifeskim:mentionsumls-concept:C1314939lld:lifeskim
pubmed-article:3461311lifeskim:mentionsumls-concept:C0599861lld:lifeskim
pubmed-article:3461311pubmed:issue5lld:pubmed
pubmed-article:3461311pubmed:dateCreated1986-9-16lld:pubmed
pubmed-article:3461311pubmed:abstractTextTo confirm that endogenous opioid-peptidergic systems and monoaminergic systems participate in the regulation of pain, the effects of a narcotic antagonist naloxone, inhibitors of enkephalin-degrading enzymes and monoaminergic blockers on persistent pain induced by formalin were investigated. Rats were given formalin into the plantar region of the left hind-paw and the duration of licking responses was measured at periods of 0-10 min (period I), 10-30 min (period II), 30-60 min (period III) and 60-120 min (period IV). Naloxone was administered systemically through mini-osmotic pumps and there was an enhanced licking response at period III and a tendency toward enhancement at period IV. The duration of the licking response at period III was increased when naloxone was given into the fourth ventricle in a dose of 30 nmol/rat, but not when it was injected into the lumbo-sacral subarachnoid space in doses of 30 and 300 nmol/rat. Thiorphan and bestatin injected simultaneously into the fourth ventricle (50 micrograms/rat) depressed the licking response at period III. Intrathecal injection of phentolamine significantly enhanced the licking response at periods I-III and produced a similar, but weaker effect at period IV. Intrathecal injection of propranolol and methysergide did not affect the response. These results suggest that opioid-peptidergic systems in the brain stem and noradrenergic systems in the spinal cord (via alpha-adrenoceptors) participate in the regulation of pain.lld:pubmed
pubmed-article:3461311pubmed:languageenglld:pubmed
pubmed-article:3461311pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3461311pubmed:citationSubsetIMlld:pubmed
pubmed-article:3461311pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3461311pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3461311pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3461311pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3461311pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3461311pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3461311pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3461311pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3461311pubmed:statusMEDLINElld:pubmed
pubmed-article:3461311pubmed:monthMaylld:pubmed
pubmed-article:3461311pubmed:issn0028-3908lld:pubmed
pubmed-article:3461311pubmed:authorpubmed-author:TakagiHHlld:pubmed
pubmed-article:3461311pubmed:authorpubmed-author:SatohMMlld:pubmed
pubmed-article:3461311pubmed:authorpubmed-author:SugimotoMMlld:pubmed
pubmed-article:3461311pubmed:authorpubmed-author:KuraishiYYlld:pubmed
pubmed-article:3461311pubmed:issnTypePrintlld:pubmed
pubmed-article:3461311pubmed:volume25lld:pubmed
pubmed-article:3461311pubmed:ownerNLMlld:pubmed
pubmed-article:3461311pubmed:authorsCompleteYlld:pubmed
pubmed-article:3461311pubmed:pagination481-5lld:pubmed
pubmed-article:3461311pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:3461311pubmed:meshHeadingpubmed-meshheading:3461311-...lld:pubmed
pubmed-article:3461311pubmed:meshHeadingpubmed-meshheading:3461311-...lld:pubmed
pubmed-article:3461311pubmed:meshHeadingpubmed-meshheading:3461311-...lld:pubmed
pubmed-article:3461311pubmed:meshHeadingpubmed-meshheading:3461311-...lld:pubmed
pubmed-article:3461311pubmed:meshHeadingpubmed-meshheading:3461311-...lld:pubmed
pubmed-article:3461311pubmed:meshHeadingpubmed-meshheading:3461311-...lld:pubmed
pubmed-article:3461311pubmed:meshHeadingpubmed-meshheading:3461311-...lld:pubmed
pubmed-article:3461311pubmed:meshHeadingpubmed-meshheading:3461311-...lld:pubmed
pubmed-article:3461311pubmed:meshHeadingpubmed-meshheading:3461311-...lld:pubmed
pubmed-article:3461311pubmed:meshHeadingpubmed-meshheading:3461311-...lld:pubmed
pubmed-article:3461311pubmed:meshHeadingpubmed-meshheading:3461311-...lld:pubmed
pubmed-article:3461311pubmed:meshHeadingpubmed-meshheading:3461311-...lld:pubmed
pubmed-article:3461311pubmed:meshHeadingpubmed-meshheading:3461311-...lld:pubmed
pubmed-article:3461311pubmed:meshHeadingpubmed-meshheading:3461311-...lld:pubmed
pubmed-article:3461311pubmed:meshHeadingpubmed-meshheading:3461311-...lld:pubmed
pubmed-article:3461311pubmed:meshHeadingpubmed-meshheading:3461311-...lld:pubmed
pubmed-article:3461311pubmed:year1986lld:pubmed
pubmed-article:3461311pubmed:articleTitleInvolvement of medullary opioid-peptidergic and spinal noradrenergic systems in the regulation of formalin-induced persistent pain.lld:pubmed
pubmed-article:3461311pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3461311pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3461311lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3461311lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3461311lld:pubmed